Inborn Errors of Immunity-the Sri Lankan Experience 2010-2022.

Inborn Errors of Immunity-the Sri Lankan Experience 2010-2022.

Dasanayake D,Bustamante J,Boisson-Dupuis S,Karunatilleke C,Thambyrajah J,Puel A,Chan K,Doffinger R,Lau Y,Casanova J,Kumararatne D,de Silva R

Source :

2023 Jul 22

Pmid / DOI:

37480474

Abstract

PURPOSEInborn errors of immunity (IEI) are typically monogenic. Data from the Indian subcontinent are relatively scarce. This paper evaluates IEI diagnosed in Sri Lanka.METHODSData of patients diagnosed with IEI from 2010 to 2022 at the Department of Immunology, Medical Research Institute, Colombo, Sri Lanka, were retrospectively analyzed.RESULTSTwo hundred and six patients were diagnosed with IEI, with a prevalence of 0.94 per 100,000. The onset of disease was below 12 years in 84.9%, whereas in 10.9%, it was after 18 years. The male: female ratio was 1.78:1. Consanguinity was identified in 26.6%. IEI were found in all but one (bone marrow failure) of the 10 IUIS categories. Predominantly antibody deficiencies were the most common category among the nine identified (30.1%), followed by combined immune deficiencies with syndromic features (21.3%), immunodeficiencies affecting cellular and humoral immunity (19.9%), congenital defects of phagocyte number or function (13.1%), and defects in intrinsic and innate immunity (8.2%). Severe combined immune deficiency (SCID) was the commonest disease (14.6%), followed by chronic granulomatous disease (CGD) (10.6%) and X linked agammaglobulinemia (8.7%). Of the patients with a known outcome (n = 184), 51 died (27.7%). Mortality rates were high in SCID (83.3%), Omenn syndrome (OS) (100%), and CGD (31.8%) patients.CONCLUSIONIEI in Sri Lanka are diagnosed mainly in childhood. The low diagnosis rates suggest a need for educating clinicians regarding IEI in adulthood. The high mortality rates associated with some IEI indicate the need of transplant services in the country.KEYWORDSChronic granulomatous disease, IEI in Sri Lanka, Inborn errors of immunity, Next generation sequencing, Severe combined immune deficiency© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

See publication

All publications